Recombinant multi-species UBE1/UBA1/UBAE1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UBE1/UBA1/UBAE1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation. This gene complements an X-linked mouse temperature-sensitive defect in DNA synthesis, and thus may function in DNA repair. It is part of a gene cluster on chromosome Xp11.23. Alternatively spliced transcript variants that encode the same protein have been described. [provided by RefSeq, Jul 2008]
The Alternative Names of target: A1S9,A1S9T,A1ST,AMCX1,CFAP124,GXP1,POC20,Protein A1S9,SMAX2,Sbx,UBA1,UBA1A,UBAE1,UBE1,UBE1X,Uba1,Ube-1,Ube1x,Ubiquitin-activating enzyme E1,Ubiquitin-like modifier-activating enzyme 1,VEXAS
Go
to UBE1/UBA1/UBAE1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0143-Ag-1/ GM-Tg-hg-IP0143-Ag-2 | Human UBE1/UBA1/UBAE1 protein | Human |
| GM-Tg-rg-IP0143-Ag-1/ GM-Tg-rg-IP0143-Ag-2 | Rat UBE1/UBA1/UBAE1 protein | Rat |
| GM-Tg-mg-IP0143-Ag-1/ GM-Tg-mg-IP0143-Ag-2 | Mouse UBE1/UBA1/UBAE1 protein | Mouse |
| GM-Tg-cynog-IP0143-Ag-1/ GM-Tg-cynog-IP0143-Ag-2 | Cynomolgus/Rhesus macaque UBE1/UBA1/UBAE1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0143-Ag-1/ GM-Tg-felg-IP0143-Ag-2 | Feline UBE1/UBA1/UBAE1 protein | Feline |
| GM-Tg-cang-IP0143-Ag-1/ GM-Tg-cang-IP0143-Ag-2 | Canine UBE1/UBA1/UBAE1 protein | Canine |
| GM-Tg-bovg-IP0143-Ag-1/ GM-Tg-bovg-IP0143-Ag-2 | Bovine UBE1/UBA1/UBAE1 protein | Bovine |
| GM-Tg-equg-IP0143-Ag-1/ GM-Tg-equg-IP0143-Ag-2 | Equine UBE1/UBA1/UBAE1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0143-Ag-1/ GM-Tg-hg-IP0143-Ag-2;
GM-Tg-rg-IP0143-Ag-1/ GM-Tg-rg-IP0143-Ag-2;
GM-Tg-mg-IP0143-Ag-1/ GM-Tg-mg-IP0143-Ag-2; GM-Tg-cynog-IP0143-Ag-1/ GM-Tg-cynog-IP0143-Ag-2; GM-Tg-felg-IP0143-Ag-1/ GM-Tg-felg-IP0143-Ag-2; GM-Tg-cang-IP0143-Ag-1/ GM-Tg-cang-IP0143-Ag-2; GM-Tg-bovg-IP0143-Ag-1/ GM-Tg-bovg-IP0143-Ag-2; GM-Tg-equg-IP0143-Ag-1/ GM-Tg-equg-IP0143-Ag-2 |
| Products Name | UBE1/UBA1/UBAE1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | UBE1/UBA1/UBAE1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UBE1/UBA1/UBAE1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.